olympia pharmaceuticals semaglutide Exploring Medication- Weight Loss: The Role Of Semaglutid GLP-1 Agonists for Weight Loss

They might also extend the dosing interval to one dose every two weeks instead of one

Notably, more than one-third of participants achieved weight loss of 25% or greater, results previously seen only with bariatric surgery

On August 28, 2025, the US Food and Drug Administration (FDA) approved Teva Pharmaceuticals generic to Novo Nordisks Saxenda (liraglutide injection)

Hormone replacement therapy (HRT) restores estrogen and/or progesterone levels, which can help ease menopause symptoms like hot flashes, brain fog, and mood swings

It activates GLP-1 receptors in the brain and gut, reducing appetite, slowing gastric emptying, and improving insulin sensitivity